Corrigendum to "Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8" [FEBS Lett. 582 (2008) 819-825] (DOI:10.1016/j.febslet.2008.02.005);Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

FEBS Letters

Volumn 582, Issue 5, 2008, Pages 819-825

  Ajami, Katerina ^a,b   Pitman, Melissa R ^c   Wilson, Claire H ^c   Park, Joohong ^a   Menz, R Ian ^c   Starr, Amanda E ^d   Cox, Jennifer H ^d   Abbott, Catherine A ^c   Overall, Christopher M ^d   Gorrell, Mark D ^a,b  

^a University of Sydney   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chemokine; Dipeptidyl peptidase 8; Dipeptidyl peptidase IV; Substrate specificity

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INFLAMMATORY PROTEIN 10; INTERFERON; PROTEIN; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 39749108674     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.02.066     Document Type: Erratum

References (27)

1. Gorrell M.D. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin. Sci. 108 (2005) 277-292
2. Abbott C.A., Yu D.M.T., Woollatt E., Sutherland G.R., McCaughan G.W., and Gorrell M.D. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur. J. Biochem. 267 (2000) 6140-6150
3. Ajami K., Abbott C.A., McCaughan G.W., and Gorrell M.D. Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. Biochim. Biophys. Acta 1679 (2004) 18-28
4. Overall C.M., and Blobel C.P. In search of partners: linking extracellular proteases to substrates. Nat. Rev. Mol. Cell. Biol. 8 (2007) 245-257
5. Thornberry N.A., and Weber A.E. Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Curr. Top. Med. Chem. 7 (2007) 557-568
6. Bjelke J.R., Christensen J., Nielsen P.F., Branner S., Kanstrup A.B., Wagtmann N., and Rasmussen H.B. Dipeptidyl peptidase 8 and 9 specificity and molecular characterization compared to dipeptidyl peptidase IV. Biochem. J. 396 (2006) 391-399
7. Lee H.J., Chen Y.S., Chou C.Y., Chien C.H., Lin C.H., Chang G.G., and Chen X. Investigation of the dimer interface and substrate specificity of prolyl dipeptidase DPP8. J. Biol. Chem. 281 (2006) 38653-38662
8. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
9. McQuibban G.A., Gong J.-H., Tam E., McCulloch C.A.G., Clark-Lewis I., and Overall C.M. Inflammation dampened by gelatinase a cleavage of monocyte chemoattractant protein-3. Science 289 (2000) 1202-1206
10. McQuibban G.A., Butler G.S., Gong J.-H., Bendall L., Power C., Clark-Lewis I., and Overall C.M. Matrix metalloproteinase activity inactivates the chemokine stromal-cell derived factor-1. J. Biol. Chem. 276 (2001) 43503-43508
11. Oravecz T., et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation normal T cell expressed and activated) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186 (1997) 1865-1872
12. Proost P., Menten P., Struyf S., Schutyser E., De Meester I., and Van Damme J. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78 beta into a most efficient monocyte attractant and CCR1 agonist. Blood 96 (2000) 1674-1680
13. Proost P., et al. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signalling and reduces lymphocyte and endothelial cell migration. Blood 110 (2007) 37-44
14. Shioda T., et al. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. USA 95 (1998) 6331-6336
15. Oberlin E., et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 (1996) 833-835
16. Kryczek I., Wei S., Keller E., Liu R., and Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am. J. Physiol. Cell Physiol. 292 (2007) C987-C995
17. Park J., Ajami K., and Gorrell M.D. Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities. In: Lendeckel U., Reinhold D., and Bank U. (Eds). Dipeptidyl Aminopeptidases in Health and Disease II (2006), Kluwer, New York 93-102
18. Clark-Lewis I., Vo L., Owen P., and Anderson J. Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. Methods Enzymol. 287 (1997) 233-250
19. Hoffmann T., and Demuth H.U. Therapeutic strategies exploiting DP IV inhibition - target disease: type 2 diabetes. In: Langner J., and Ansorge S. (Eds). Ectopeptidases: CD13/Aminopeptidase N and CD26/Dipeptidylpeptidase IV in Medicine and Biology (2002), Kluwer, New York 259-278
20. Ajami K., Abbott C.A., Obradovic M., Gysbers V., Kähne T., McCaughan G.W., and Gorrell M.D. Structural requirements for catalysis, expression and dimerisation in the CD26/DPIV gene family. Biochemistry 42 (2003) 694-701
21. Lambeir A.M., et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J. Biol. Chem. 276 (2001) 29839-29845
22. Proost P., et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98 (2001) 3554-3561
23. Frerker N., et al. Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Peptides 28 (2007) 257-268
24. Rasmussen H.B., Branner S., Wiberg F.C., and Wagtmann N. Crystal structure of human DPP-IV/CD26 in complex with a substrate analogue. Nat. Struct. Biol. 10 (2003) 19-25
25. Pitman M.R., Menz R.I., and Abbott C.A. Prediction of dipeptidyl peptidase 8 structure by homology modelling. In: Lendeckel U., Reinhold D., and Bank U. (Eds). Dipeptidyl Aminopeptidases: Basic Science and Clinical Applications (2006), Kluwer, New York 33-42
26. Rummey C., and Metz G. Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site. Proteins 66 (2007) 160-171
27. Overall C.M., McQuibban G.A., and Clark-Lewis I. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol. Chem. 383 (2002) 1059-1066